share_log

SentinelOne, AeroVironment, PVH And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Benzinga ·  Dec 5, 2024 21:34

U.S. stock futures were slightly lower this morning, with the Dow futures falling around 0.1% points on Thursday.

Shares of SentinelOne, Inc. (NYSE:S) fell sharply in today's pre-market trading following third-quarter results.

SentinelOne reported third-quarter revenue of $210.65 million, beating the consensus estimate of $209.72 million, according to Benzinga Pro.

Total revenue increased 28% year-over-year. Annualized recurring revenue (ARR) increased 29% to $859.7 million as of Oct. 31. Customers with ARR of $100,000 or more grew 24% to 1,310 in the quarter. The company ended the quarter with $1.1 billion in cash, cash equivalents and investments.

SentinelOne shares dipped 14.7% to $24.45 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

  • nCino, Inc. (NASDAQ:NCNO) fell 18.7% to $34.50 in pre-market trading after the company reported third-quarter financial results and issued fourth-quarter revenue guidance below estimates.
  • American Eagle Outfitters, Inc. (NYSE:AEO) fell 14.4% to $17.59 in today's pre-market trading after the company reported a year-over-year decrease in third-quarter sales results. Also, the company said it expects a 4% decrease in fourth-quarter total revenue.
  • ZJK Industrial Co., Ltd. (NASDAQ:ZJK) declined 14.3% to $11.70 in pre-market trading.
  • KB Financial Group Inc. (NYSE:KB) dropped 9.3% to $61.00 in pre-market trading.
  • Synopsys, Inc. (NASDAQ:SNPS) dipped 8.4% to $538.60 in pre-market trading after the company issued first-quarter guidance below estimates.
  • AeroVironment, Inc. (NASDAQ:AVAV) fell 8.1% to $181.04 in pre-market trading after the company announced quarterly financial results.
  • PVH Corp. (NYSE:PVH) fell 7% to $105.00 in pre-market trading following third-quarter results.
  • Mesoblast Limited (NASDAQ:MESO) fell 6.4% to $10.72 in pre-market trading. The FDA granted Mesoblast's Revascor Regenerative Medicine Advanced Therapy Designation in children with congenital heart disease.
  • Rambus Inc (NASDAQ:RMBS) fell 3.8% to $56.71 in pre-market trading.

Now Read This:

  • Dow Settles Above 45,000 For First Time As Salesforce, Marvell Surge: Investor Sentiment Improves, Fear Index In 'Greed' Zone
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment